BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7032933)

  • 1. Biological markers as prognostic and clinical evaluation tools.
    Tormey DC; Waalkes TP
    Eur J Cancer (1965); 1980; Suppl 1():21-4. PubMed ID: 7032933
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor associated markers in breast cancer.
    Franchimont P; Zangerle PF; Colin C; Osterrieth P; Hendrick JC; van Cauwenberge JR; Hustin J
    Eur J Cancer (1965); 1980; Suppl 1():17-20. PubMed ID: 6172278
    [No Abstract]   [Full Text] [Related]  

  • 3. A biochemical approach to the staging of human breast cancer.
    Coombes RC; Powles TJ; Gazet JC; Ford HT; Nash AG; Sloane JP; Hillyard CJ; Thomas P; Keyser JW; Marcus D; Zinberg N; Stimson WH; Neville AM
    Cancer; 1977 Aug; 40(2):937-44. PubMed ID: 890676
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of carcinoembryonic antigen test in human mammary carcinoma.
    Batabyal SK; Ghosh SN; Roy NK; Mehrotra YN; Gupta A
    Indian J Pathol Microbiol; 1987 Oct; 30(4):407-12. PubMed ID: 3507401
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear medicine procedures in obstetrics and gynecology.
    Gorten RJ
    Radiol Clin North Am; 1974 Apr; 12(1):147-65. PubMed ID: 4820825
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical markers in breast carcinoma.
    Duffy MJ; Hynes N; Groarke Y; Oliver J; O'Broin A; Duffy G
    Ir Med J; 1978 Sep; 71(12):408-13. PubMed ID: 700980
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoembryonic antigen (CEA): its role as a tumour marker in breast cancer.
    Doyle PJ; Nicholson RI; Groome GV; Blamey RW
    Clin Oncol; 1981 Mar; 7(1):53-8. PubMed ID: 7214765
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor markers for breast cancer. Current utilities and future prospects.
    Hayes DF
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):485-506. PubMed ID: 8707769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Predictive value of hydroxyproline: creatinine ratio in advanced breast cancer.
    Roberts JG; Baum M
    Br Med J; 1975 Jun; 2(5970):559. PubMed ID: 1148708
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic markers and breast cancer.
    Waalkes TP; Tormey DC
    Semin Oncol; 1978 Dec; 5(4):434-44. PubMed ID: 83677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carcinoembryonic antigen in breast tumors: initial evaluation and monitoring].
    Bolla M; Daidj H; Lachet B; Bouchet Y; Vrousos C
    Bull Cancer; 1983; 70(4):300-2. PubMed ID: 6652251
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical value of TPS, CEA and CA 15-3 in breast cancer patients.
    Blijlevens NM; Oosterhuis WP; Oosten HR; Mulder NH
    Anticancer Res; 1995; 15(6B):2711-6. PubMed ID: 8669851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoembryonic antigen in bone metastases. Diagnostic and prognostic value].
    Colson F; Gioud M; Bonvoisin B; Lejeune E; Bouvier M
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):621-5. PubMed ID: 6523014
    [No Abstract]   [Full Text] [Related]  

  • 15. The value of sequential marker estimations following mastectomy for breast cancer.
    Coombes RC; Powles TJ; Ford HT; Gazet JC; Gehrke CW; Keyser JW; Mitchell PE; Patel S; Stimson WH; Abbott M; Worwood M; Neville AM
    Eur J Cancer (1965); 1980; Suppl 1():25-30. PubMed ID: 6119202
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum carcinoembryonic antigen levels in breast cancer].
    Haim N; Bartal AH; Cohen Y; Cordova T; Ayalon D
    Harefuah; 1980 Feb; 98(4):152-4. PubMed ID: 7399356
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue CEA as a prognostic factor in patients with breast cancer].
    Haase W
    Strahlenther Onkol; 1995 Feb; 171(2):117-8. PubMed ID: 7863426
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of biochemical markers in breast cancer.
    Coombes RC; Powles TJ; Neville AM
    Proc R Soc Med; 1977 Dec; 70(12):843-5. PubMed ID: 601063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.